In the present study, we analyzed the role of Lys191 on function, structure, and dynamic behavior of the human GnRH receptor (hGnRHR) and the formation of the Cys14-Cys200 bridge, which is essential for receptor trafficking to the plasma membrane. Several mutants were studied; mutants lacked either the Cys14-Cys200 bridge, Lys191 or both. The markedly reduced expression and function of a Cys14Ser mutant lacking the 14-200 bridge, was nearly restored to wild-type/DLys191 levels upon deletion of Lys191. Lys191 removal resulted in changes in the dynamic behavior of the mutants as disclosed by molecular dynamics simulations: the distance between the sulfur-(or oxygen-) sulfur groups of Cys (or Ser)14 and Cys200 was shorter and more constant, and the conformation of the NH 2 -terminus and the exoloop 2 exhibited fewer fluctuations than when Lys191 was present. These data provide novel information on the role of Lys191 in defining an optimal configuration for the hGnRHR intracellular trafficking and function.
Introduction
The mammalian GnRH receptor (GnRHR) type I (hereafter referred as GnRHR) belongs to the superfamily of G-protein coupled receptors (GPCRs), specifically, to the family related to the rhodopsin-and b 2 -adrenergic-like receptors (Family A; Ulloa-Aguirre & , Millar et al. 2004 ). The GnRHR is located in the pituitary gonadotroph and is bathed by the circulation of the hypothalamic-pituitary portal system which transfers pulsatile signals of the hypothalamic decapeptide, GnRH. The gonadotroph cell responds with a concomitant pulsatile release of the gonadotrophins, LH and FSH (Santen & Bardin 1973 , Knobil 1974 . These enter the peripheral circulation and regulate gonadal steroidogenesis, along with gametogenesis.
The GnRHR is among the smallest members of the GPCR superfamily (328 amino acid residues in the human GnRHR (hGnRHR)); unlike other members of the rhodopsin/b-adrenergic subfamily of GPCR, including the type II GnRHR (Millar 2003) , the GnRHR exhibits several unique features such as the reciprocal change of the conserved Asp and Asn residues in transmembrane domains (TM) 2 and 7 (Awara et al. 1996) , the replacement of Tyr with Ser in the highly conserved Asp-Arg-Tyr (DRY) motif located in the junction of the TM3 and the intracellular loop (IL) 2, and the lack of the carboxyl-terminal extension into the cytosol (McArdle et al. 1999 , Millar 2003 , Millar et al. 2004 , whose presence is associated with differential physiological receptor regulation (Heding et al. 1998 , Lin et al. 1998 . Another important feature of the GnRHR is the amino acid residue at position 191 in the extracellular loop (EL) 2, which is frequently Glu or Gly in many mammals, but is replaced with Lys in primates , Ulloa-Aguirre et al. 2006 ; in rat and mice GnRHR (327 amino acid residues) this amino acid is absent, conferring the GnRHR increased cell surface membrane expression for agonist (Arora et al. 1999) . Knowledge of the structural requirements that govern GnRHR intracellular trafficking and cell surface membrane expression is of prime importance considering that this receptor is presently a therapeutic target for a number of pathological conditions such as prostate cancer, uterine fibroids, endometriosis, and precocious puberty.
The amino acid sequence of the hGnRHR predicts formation of two disulfide bridges at extracellular regions, one connecting the first and second ELs (Cys114-Cys196) and the second connecting the amino terminal extension with the EL2 (Cys14-Cys200; Millar et al. 2004) . The first bridge that involves two highly conserved cysteine residues is a structural feature present in many GPCRs and it is associated with the fundamental stability of the seven transmembrane structure (Ulloa-Aguirre . The functional significance of the Cys14-Cys200 bridge differs depending on the receptor species (Knollman et al. 2005) . In the rat, this bridge is not essential for optimal function of the GnRHR as replacement of the Cys residues at either end of the bridge does not affect plasma membrane expression and agonist-stimulated intracellular signaling (Cook & Eidne 1997 , whereas in the mouse GnRHR, breakage of this bridge results in w50% decrease in receptor function (Knollman et al. 2005) . In the human receptor, formation of this bridge is an absolute requirement for efficient routing and plasma membrane expression of the receptor as bridge-breaking mutants Cys200Tyr (a naturally occurring mutation in humans; Beranova et al. 2001) , Cys14Ala and Cys200Ala exhibit either none or marginal activity; further, exposure to these mutants to pharmacological chaperones (i.e., small molecules that serve as molecular scaffolding to promote correct folding of otherwise misfolded mutant proteins), normalize receptor function indicating that the absence of the bridge resulted in a misfolded protein (Leanos-Miranda et al. 2002 , Knollman et al. 2005 .
The structural determinants that lead to the requirement of the Cys14-Cys200 bridge in folding and plasma membrane expression of the hGnRHR have been defined by mutagenesis experiments . These studies revealed that residues located in the NH 2 -terminus and in the EL2 as well as sequences flanking this loop (i.e., within TMs 4 and 5) and those that abut on that area (ELs 1 and 3), presumably control the destabilizing role of Lys191 on the formation of the Cys14-Cys200 bridge. In fact, removal of Lys191 from misfolded hGnRHR mutants (including Cys14Ala and Cys200Tyr mutants) led to partial or complete functional recovery of the altered receptors indicating that the association Cys14-Cys200 may be potentially disrupted or diminished by the presence of Lys191, which is present in primate GnRHRs and absent in mice and rat receptors (Leanos-Miranda et al. 2002 .
In the present study, we applied a combined strategy (mutagenesis and functional studies as well as computational modeling and molecular dynamics (MD) simulations) to analyze the role of Lys191 on the functional, structural, and dynamic behavior of the hGnRHR. A model of the wildtype (Wt) hGnRHR in explicit dipalmitoyl phosphatidyl choline bilayers, recently developed in our laboratory and further refined by intensive MD simulations (Jardon-Valadez et al. 2008) , was employed as reference structure for the mutations and structural modifications. Both experimental and theoretical results provide new insights at the atomic level into this issue, and indicate that the absence of Lys191 favors the interactions between the EL2 and the NH 2 -teminus, the formation of the Cys14-Cys200 disulfide bridge, and the acquisition of a hGnRHR configuration compatible with high-plasma membrane expression and function, even in the absence of the Cys14-Cys200 bridge.
Materials and Methods

Construction of hGnRHR mutants
A hGnRHR lacking the apparent disulfide bridge at positions 14 and 200 was constructed by replacing Cys at position 14 of the Wt receptor with Ser as previously reported (Davidson et al. 1997) . Construction of the hGnRHR Cys14Ser mutant was performed employing the full-length Wt hGnRHR cloned into pcDNA3.1 at KpnI and XbaI restriction enzyme sites. Site-directed mutagenesis was performed using the Quick Change site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA), following the manufacturer instructions. Mutagenic oligonucleotides (Life Technologies; forward:
0 ) were designed according to the cDNA sequence reported for the hGnRHR (GenBank accession no. L07949; Chi et al. 1993) . The hGnRHR Cys14Ser/DLys191 mutant was constructed by the above described mutagenesis procedure employing a Wt receptor sequence (cloned in pcDNA3.1) lacking lysine at position 191 (hGnRHR/DLys191; Maya-Nunez et al. 2002) as template. For transfection, large-scale plasmid DNAs were prepared using an Endofree maxiprep kit (Qiagen). The identity of all constructs was verified by automated sequencing employing the BigDye Terminator Cycle Sequence kit (Applied Biosystems, Foster City, CA, USA).
Transient transfection of COS-7 cells
Wt and mutant hGnRHRs were transiently expressed in COS-7 cells as described . Fifty thousand or 1000 cells per well were plated in 48-well plates (for assessing inositol phosphate (IP) production) or 24-well plates (for binding experiments; Costar, Cambridge, MA, USA), respectively, and 20 h later the cells were transfected with 0 . 050 or 0 . 2 mg (for IP production or binding studies respectively) hGnRHR DNA constructs per well, using liposome-mediated endocytosis, as described (Leanos-Miranda et al. 2005) . After transfection, the cells were washed twice with DMEM/0 . 1% BSA/gentamicin and preloaded with 4 mCi/ml [ 3 H]-myoinositol (for IP assays) or DMEM (for binding studies) as described below. IP production was measured after exposure of the cells to the GnRH agonist, Buserelin (Sigma) for 2 h.
Measurement of IP production
Quantification of IP production by Dowex anion exchange chromatography and liquid scintillation spectroscopy was performed as described previously (Huckle & Conn 1987) .
Receptor binding assay COS-7 cells were transiently transfected as described above. Twenty hours after the start of transfection, the cells were washed twice with warm DMEM/0 . 1% BSA/10 mM HEPES and cultured in DMEM for 18 h before addition of [ 125 I]-Buserelin (specific activity 700 mCi/mg). Cells were incubated at room temperature for 90 min in the presence or absence of excess (10 mM) unlabelled ligand (Buserelin; Sigma) plus [ 125 I]-Buserelin. Thereafter, the medium was removed, the plates containing the cells were placed on ice, washed twice with ice-cold PBS, and then the cells were solubilized by the addition of 0 . 2 M NaOH/0 . 1% SDS. Aliquots of samples were then transferred to glass tubes and counted in a g-counter (Packard Instruments, Downers Grove, IL, USA). Specific binding was calculated by subtracting non-specific binding (binding measured in the presence of 10 mM Buserelin) from total binding (no GnRH agonist added).
For the radioreceptor assay, COS-7 cells were transfected as described above and incubated at room temperature for 90 min in the presence or absence of excess Buserelin plus
125 I]-Buserelin plus increasing concentrations (10 K11 to 10 K6 ) of the unlabelled ligand. Thereafter, the medium was removed and the plates containing the cells were placed on ice and washed twice with ice-cold PBS. The cells were then solubilized by the addition of 0 . 2 M NaOH/0 . 1% SDS. Aliquots of samples were then transferred to glass tubes and counted in a g-counter.
Mutations and structural modifications on the Wt hGnRHR for computational modeling and MD simulations Five mutations/structural modifications were introduced on a refined hGnRHR model (Jardon-Valadez et al. 2008) . Mutant hGnRHR Cys14k200Cys was identical to the original model but with the Cys14-Cys200 disulfide bridge disrupted by reducing both Cys residues. Lysine 191 was deleted in the Wt hGnRHR structure to yield the hGnRHR/DLys191 structure. The two previous structural modifications were simultaneously applied to generate the mutant hGnRHR Cys14k200Cys/DLys191. To propose structure-functional relationships with the results obtained from the mutagenesis and biochemical experiments, GnRHR Cys14Ser and hGnRHR Cys14Ser/DLys191 mutant computational models were also generated and simulated. Residue substitutions were performed by keeping the backbone atom coordinates of the original structure and replacing the side chains. Rupture of disulfide bridges required the elimination of the corresponding bond restraint from the potential function and the addition of the reducing hydrogen atom in both Cys residues. Deletion of Lys191 was directly performed on the coordinates file of the Wt receptor model, with the peptide bond between Thr190 and Val192 being imposed. In all cases, the steepest descent minimization was performed to prevent unfavorable contacts and highly unstable interactions. Water molecules and lipids present in the original model were preserved in such a manner that only the local environment of the modified EL2 was perturbed. After minimization, a short molecular dynamics relaxation was performed and thereafter three different 35-ns-long MD simulations at 310 K and constant volume were performed for each system. The temperature of the simulations was chosen to reproduce physiological conditions of the protein. Three MD simulations of the refined Wt hGnRHR model (JardonValadez et al. 2008) were performed and used as control runs.
Simulation parameters
All systems consisted of 15 449 water molecules, 192 lipid molecules, the mutant receptor structure, and 15 or 14 chlorine ions, depending on the presence or absence of Lys191. Periodic boundary conditions were imposed for a simulation box of 7 . 6!7 . 6!13 nm 3 . A total of 18 MD simulations were performed using the GROMACS package (version 3.3.1; Berendsen et al. 1995 , Lindahl et al. 2001 , Van Der Spoel et al. 2005 . The extended simple point charge (SPC/E) water model (Berendsen et al. 1987 ) was used while the 53a6 parameterization of the GROMOS96 force field (Oostenbrink et al. 2004 ) was employed for the protein and the lipid molecules. Water, protein, lipids, and ions were separately coupled to an external temperature bath (using a coupling constant of 0 . 1 ps) by means of a Berendsen thermostat (Berendsen et al. 1984) . The long-range interactions were calculated using the efficient Particle Mesh Ewald (Darden et al. 1993 , Essman et al. 1995 ) with a real space cut-off of 0 . 9 nm, a 0 . 12 nm space grid, and a fourth order B-spline interpolation scheme. The equations of motion were integrated using the leap-frog method (Hockney & Eastwood 1988 ) with a 2 fs time step. The bond lengths and H-O-H angle in water were constrained using the SETTLE algorithm (Miyamoto & Kollman 1992) , while the LINCS algorithm (Hess et al. 1997 ) was used to constrain bond lengths in the receptor and lipid molecules. All atom coordinates were stored every 10 ps. The initial velocities of the atoms were randomly assigned to produce a Maxwell distribution corresponding to the temperature at which the simulation will be performed.
Analysis of the trajectories
Root mean square positional deviations (RMSD) of the whole protein backbone, the backbone of the transmembranal domains, and the backbone atoms of the ELs together with those of the NH 2 -terminus were calculated throughout the trajectories. Additionally, in order to compare the time evolution of the mutants' trajectories with those of the Wt receptor, RMSD matrices for the a-carbons were calculated. These matrices provide a global comparison of every structure reached along a particular trajectory of a mutant with those sampled for the Wt receptor in a different trajectory. RMS positional fluctuations (RMSF) per residue were also calculated over the last 15 ns of the trajectory. The S-S (or O-S in Cys14Ser mutants) distances between the sulfur atom of Cys14 (or the oxygen atom of Ser14) and that of Cys200 were determined as a function of time. The blocking average method (Flyvbjerg & Petersen 1989 ) was used to calculate the S.D. for the S-S distance. Hydrogen bonds between extracellular amino acid residues were also calculated for the trajectories involving the Cys14Ser mutation using a donor-acceptor atom cutoff distance of 3 . 5 Å and a donorhydrogen-acceptor angle of !308. All analyses were performed using tools from the GROMACS 3.3.1 package (Berendsen et al. 1995 , Lindahl et al. 2001 , Van Der Spoel et al. 2005 , the viewers RASMOL 2.7 (Sayle & Milnerwhite 1995) , VMD 1.8.2 (Humphrey et al. 1996) , Pymol 0 . 99 (De Lano 2002) , and several computer programs and scripts specifically developed for this purpose.
Statistical analysis
Data from the biochemical studies were analyzed with oneway ANOVA and then with the Walker-Duncan adaptive procedure. Binding parameters were calculated from the doseresponse displacement curves using the software GraphPad Prism 4.0 (GraphPad Software Inc., La Jolla, CA, USA).
Results
Functional studies
As shown in Fig. 1A , all hGnRHRs expressed in COS-7 cells specifically bound 125 I-Buserelin. In the absence of the Cys14-Cys200 disulfide bridge (hGnRHR Cys14Ser mutant) maximally bound radiolabelled GnRH analog was considerably reduced (at levels 17G2% from that exhibited by the Wt receptor). The binding capability of Wt and mutant hGnRHRs to which Lys191 was removed, markedly increased as compared with their corresponding counterparts bearing this amino acid. Maximal binding of radiolabelled Buserelin to the Cys14Ser/DLys191 mutant, however, remained below (at levels 67G8%) that shown by the Wt hGnRHR. The reduced maximal 125 I-Buserelin binding of the hGnRHR Cys14Ser/DLys191 mutant was apparently due to a decreased relative binding affinity of agonist for this altered receptor (Fig. 1B and Table 1 ), since the number of functional mutant Cys14Ser/DLys191 receptors at the cell surface increased to levels between those of Wt receptor bearing and lacking Lys191.
Despite the markedly reduced analog binding capacity of the hGnRHR lacking the Cys14-Cys200 disulfide bridge this modification did not abolish completely agoniststimulated activation of the receptor (Fig. 1C and In silico analysis of Wt and mutant hGnRHRs structure
To assess the role of lysine at position 191 on receptor conformation, three independent trajectories for each mutant generated were monitored by all-atom MD simulations. In all runs, the overall protein structure was well preserved as disclosed by the convergence of the backbone RMSD shown in Figure S1 (see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinologyjournals.org/content/vol201/issue2/). RMSD values for the three replicas and the contribution for the helices backbone are also included in the figure. Except for a run in the hGnRHR Cys14k200Cys mutant, all RMSD values were lower than 3 . 0 Å throughout the corresponding trajectories.
Likewise, the RMSD values for the helices backbone was close to 2 . 0 Å in all cases. Similar deviations from those configurations sampled in an extended trajectory of the hGnRHR model were detected in all mutant structures ( Figure S2 , see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinologyjournals.org/content/vol201/issue2/). Removal of the Cys14-Cys200 disulfide bridge by reducing both Cys residues (hGnRHR Cys14k200Cys) or replacing Cys14 by Ser (mutant hGnRHR Cys14Ser) as well as elimination of lysine at position 191 (mutant hGnRHR/DLys191) from the Wt receptor resulted in evident conformational changes on the simulated receptor structures. The double mutations involving deletion of Lys191 (mutants hGnRHR Cys14k200Cys/DLys191 and Cys14Ser/DLys191) did not present major conformational changes as revealed by their corresponding RMSD values which were comparable with the contributions of the single mutations. In fact, the configuration of hGnRHR Cys14k200Cys/DLys191 would seem to be more similar to the Wt structure than the Cys14k200Cys receptor (which includes Lys191; Figure S2 ). As mentioned above, the structural stability of the helice domains suggested that major conformational changes were expected to occur in the extracellular domains (NH 2 -terminus and ELs). The RMSDs for the extracellular domains (backbone atoms) and the second EL from one representative run are separately shown in Fig. 2 ; equivalent plots for the other two runs are included in Figure S3 (see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinology-journals.org/content/vol201/ issue2/). Similar time-related profiles were observed for each pair of RMSD, indicating that this analysis was not able to clearly distinguish between different mutants. These plots, together with the RMSD values displayed in Figure S1 , also show that the main contribution to the conformational changes of the extracellular domain came from the EL2 and its environment. Figure S4 (see Supplementary data in the online version of the Journal of Endocrinology at http://joe.endocrinologyjournals.org/content/vol201/issue2/) shows the RMSFs per residue for the Wt and mutant structures. Residues in the TMs 1-7 were relatively static, while major mobilities were observed in the intra-and ELs, as usually found in other GPCRs (Colson et al. 1998) . Lysine 191 in the Wt and hGnRHR Cys14k200Cys structures (or Val192 in hGnRHR/DLys191, hGnRHR Cys14k200Cys/DLys191, and hGnRHR Cys14Ser/DLys191) is located in the EL2, which is a highly-dynamic domain. In general, maxima and minima RMSF values appeared in the same receptor domains for all mutants and replicas, and although no clear correlations with the presence or absence of Lys191 were detected by this type of analysis, larger fluctuations were observed in those mutants including Lys191 ( Figure S4 ). Nevertheless, differences in Cys14-Cys200 (or Ser14-Cys200) distances were noticed between the hGnRHR Cys14k200Cys and hGnRHR Cys14k200Cys/DLys191 (or hGnRHR Cys14Ser and hGnRHR Cys14Ser/DLys191) structures. Figure 3 and Table 2 show the distance between sulfur atoms of Cys14 and Cys200 for the hGnRHR Cys14k200Cys and hGnRHR Cys14k200Cys/DLys191 structures as well as that between the oxygen atom of Ser14 and Cys200 for the hGnRHR Cys14Ser and hGnRHR Cys14Ser/DLys191 structures as a function of time and for the three replicas of each system. Specifically, in structure hGnRHR Cys14k200Cys, the S-S distance increased from the initial bond distance to an average of 9 . 85G0 . 45 Å in the second run and to 6 . 22G0 . 11 Å in the third run. By contrast, in hGnRHR Cys14k200Cys/ DLys191 (lacking Lys191) the S-S distance was shorter and more constant in the three replicas even in the absence of the 14-200 disulfide bridge. In the hGnRHR Cys14Ser structure (bearing Lys191), the O-S distance increased up to 7 . 74G0 . 23 Å in the first run and was clearly larger in the other two runs than in hGnRHR Cys14k200Cys/DLys191. For the mutant hGnRHR Cys14Ser/DLys191, the O-S distance average was 3 . 75G0 . 08 Å and 4 . 45G0 . 10 Å for the first and second run respectively. Thus, a trend towards more constant and shorter distances between residues at positions 14 and 200 (at the NH 2 -terminus and the EL2 respectively) was present in those structures lacking Lys191. The first run of hGnRHR Cys14k200Cys and the third run in hGnRHR Cys14Ser/DLys191 may be considered as borderlines for this trend. Computational limitations did not allow generation of significantly longer trajectories that may clarify whether the corresponding conformations were kinetically trapped. The distances between the residues 14 and 200 of selected final configurations are compared with Wt structure in Fig. 3 .
Finally, H-bond networks on hGnRHR Cys14Ser and hGnRHR Cys14Ser/DLys191 mutants were analyzed. H-bond pathways involving Ser14, Ser201 (Ser200 when Lys was absent), Ser301 (Ser300), Asp302 (Asp301), and several water molecules around these residues were clearly observed in both receptor structures. These interactions allowed preservation of a serine-rich microdomain even in the absence of the Cys14-Cys200 bridge (Fig. 4A) . Interestingly, the formation of those H-bond networks involved less water molecules in the absence of Lys191 (Fig. 4B ).
Discussion
As with other GPCRs, a large percentage of the Wt hGnRHR is normally retained in the endoplasmic reticulum and never reaches the cell surface plasma membrane (Ulloa- Aguirre et al. 2004 ). This limited plasma membrane expression of the Wt hGnRH contrasts with that shown by the Wt rat GnRHR, whose cell surface membrane expression exceeds, by more than twofold, that presented by its human counterpart ( Janovick et al. 2003b . Among the structural differences between these GnRHRs is the presence of Lys191 in the EL2 of the human receptor, which is frequently glutamic acid or glycine in other non-primate mammalian species (Arora et al. 1999 , Ulloa-Aguirre et al. 2006 . Deletion of Lys191 from the hGnRHR or exposure to pharmacological chaperones, markedly increase plasma membrane expression of the Wt receptor to levels comparable with those of the rat GnRHR , Janovick et al. 2003a ,b, 2006 , indicating that the presence of Lys191 limits plasma membrane expression of the human receptor presumably by destabilizing the protein structure (Arora et al. 1999) . The presence and location of Lys191 in the hGnRHR is of particular interest, since the EL2 is one of the receptor regions showing the largest fluctuations in mobility as indicated by molecular dynamics simulation studies ( Jardon-Valadez et al. 2008; present study) . Although the entire EL2 consists of 27 amino acid residues the presence of two disulfide bonds divides this loop into three distinct segments separated by Cys196 and Cys200. The first segment has five hydrophobic and six polar, non-charged residues as well as Lys191, which exhibits the highest dynamic fluctuations within the EL2 of the receptor ( Jardon-Valadez et al. 2008) .
Mutational and biochemical studies have shown that Lys191 in the hGnRHR destabilizes the association between Cys14 and Cys200, which forms a disulfide bridge that is required for optimal routing of this particular receptor to the cell surface membrane , Ulloa-Aguirre et al. 2006 . Apparently, the effect of Lys191 is not wholly an effect of charge because replacement by Ala, Glu, or Gln is also associated with inefficient cell surface membrane expression of the Wt hGnRHR compared with the hGnRHR/DLys191 variant . In fact, replacement of Cys14 or Cys200 with Ala, resulted in almost complete loss of IP production, which was restored to nearly Wt levels by pharmacological chaperones or by deleting Lys191 , suggesting that the absence of this bridge in the presence of Lys191 yielded a misfolded protein. In the present study, a hGnRHR lacking the apparent disulfide bridge between residues 14 and 200 was constructed by replacing Cys at position 14 of the Wt receptor with Ser. Despite binding of the GnRH agonist being reduced, the Cys14Ser mutant receptor displayed clearly detectable functional activity (60% of that exhibited by the Wt receptor) but with a rightward shift in the dose-response curve for IP production. These findings are fully consistent with previous data (Davidson et al. 1997) and suggest that they more likely resulted from both decreased cell surface membrane expression and low-agonist binding provoked by configurational changes in the NH 2 -terminus and also probably in the EL2 (see below). Furthermore, removal of Lys191 from this particular Cys14-Cys200 bridgelacking mutant completely restored both plasma membrane expression and agonist-stimulated IP production to levels comparable with those exhibited by the Wt receptor lacking Lys191, despite an approximately twofold reduction in binding affinity of the agonist. The fact that removal of Lys191 from the Wt receptor only slightly altered the binding affinity of the receptor for GnRH agonist (Arora et al. 1999; present study) and that, in contrast to the Cys14Ser mutant, removal of Lys191 from the Cys14Ala mutant restored receptor function to levels comparable with those of the Wt receptor but well below those achieved by the hGnRHR/ DLys191 ) strongly suggests that replacement of Cys14 with Ser resulted in gain-of-function of the altered hGnRHR, in which binding affinity was dissociated from receptor activation. In this scenario, removal of Lys191 from the Cys14Ser mutant not only allowed maximal cell surface membrane expression of the receptor but also evidenced the effect of the substitution on the configuration of the receptor and its impact in receptor activation. A similar gain-of-function in receptor activity has been previously detected in a triple mutant hGnRHR with particular substitutions at positions 4, 7, and 10 of the NH 2 -terminus . In the case of the hGnRHR Cys14Ser mutant, our structural analysis suggests that the serine residue was involved in the formation of an extracellular H-bond network (Fig. 4) that, on the one hand, stabilized a particular receptor conformation but, on the other, disturbed binding of agonist due to interactions with Asp302 (Millar et al. 2004 ). This can not be achieved by the Cys14Ala or the Cys14Tyr mutations due to the hydrophobic character of alanine and tyrosine. Although the H-bonds-stabilized conformation could affect the orientation and/or mobility of particular TM helices (e.g., TM1 and/or TM7) such structural changes could not be detected in our limited time-scale MD simulations. Nevertheless, it is conceivable that changes in the configuration of the NH 2 -terminus may potentially influence the orientation of the adjacent TM1, and indirectly the intramolecular interactions between Asn53, Asn87 (in TM2), and Asp319 (in TM7) necessary for favoring the equilibrium between the active and inactive conformations of the receptor towards the inactive state (Millar et al. 2004) . Changes in the conformation of the TM1 may also affect the interaction between Lys36 and Asn102 (Jardon-Valadez et al. 2008), the latter involved in GnRH binding (Davidson et al. 1996) .
Previous mutagenesis studies have documented the functional impact of the differences between the rat GnRHR (no Lys191, high plasma membrane expression) and the hGnRHR (Lys191 present, inefficient plasma membrane expression) sequences and identified those amino acid residues that control the destabilizing influence of Lys191 on the formation of the Cys14-Cys200 disulfide bridge (Knollman et al. 2005 . In the present study, we performed MD simulations to analyze the effects of Lys191 on the three-dimensional structure and dynamic behavior of the hGnRHR. For these studies, we departed from a previously refined model of the Wt hGnRHR in an explicit lipid bilayer ( Jardon-Valadez et al. 2008) . All single mutations resulted in configurational changes on the extracellular domains of hGnRHR. Dynamic and structural analysis revealed that the presence of Lys191 provokes a tension between residues at positions 14 and 200, whereas its absence shortens and makes the distance between this pair of residues more stable. Moreover, the distance between Ser14 and Cys200 in the Cys14Ser mutant seemed relatively short and regular (even in the presence of Lys191), probably due to the participation of Ser14 in H-bonds network that may favor receptor stabilization in an active conformation. These results are in line with the assumption derived from mutagenesis studies , Ulloa-Aguirre et al. 2006 ) regarding the crucial role of Lys191 as well as residues in positions 112, 208, 300, and 302 in determining the final conformation of the EL2 and its association with the Table 2 Average distances between sulfur atoms of Cys14-Cys200 or oxygen and sulfur of Ser14-Cys200 for the last 20 ns of each trajectory S.D. were calculated using the block average method (Flyvbjerg & Petersen 1989) . Data were collected during 35 ns (45 ns for Cys14k200Cys/DLys191) for every 10 ps.
NH 2 -terminal domain of the receptor. Apparently, the proximity between these two receptor domains represents a fundamental requisite for correct folding and intracellular trafficking of the GnRHR to the plasma membrane. In the Wt rat GnRHR, proximity between the NH 2 -terminus and the EL2 is ensured by specific amino acid residues located in several domains, including the TM4, EL2, and TM5, without the need for the formation of the Cys14-Cys199 bridge , whereas in the Wt hGnRHR (which bears particular amino acids that co-evolved with and presumably control the destabilizing influence of Lys191), the association between these domains needs to be stabilized by the Cys14-Cys200 disulfide bridge, whose rate of formation depends on the proximity between these two cysteine residues (Wedemeyer et al. 2000) . In this scenario, shorter distances would presumably favor the formation of a stable Cys14-Cys200 disulfide bridge within an efficient time frame during the folding process of the receptor protein thereby reducing its degradation in proteasomes. In summary, this study provides further evidence of the role of Lys191 in the EL2 of the GnRHR in defining the configuration and the association of this loop with the NH 2 -terminus through an interaction between residues in positions 14 and 200, which in the human receptor is mediated by formation of a disulfide bridge. In the absence of Lys191, the cell surface expression of the hGnRHR is enhanced even in the absence of the Cys14-Cys200 bridge. Our findings also offer additional information on the effects of substitutions at Cys14, overemphasizing on the importance of this particular residue in defining the tertiary structure, and function of the hGnRHR.
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